Atrial fibrillation ablation in patients with arrhythmia-induced cardiomyopathy: a prospective multicentre study.
Teba Gonzalez FerreroMarco BergontiJosé Nicolás López-CanoaFederico García-Rodeja AriasSonia Eiras PenasFrancesco SperaAdrián González-MaestroCarlos Minguito-CarazoJosé Luis Martínez-SandeLaila González-MelchorFrancisco Javier García-SearaJesús Alberto Fernández-LópezEzequiel Álvarez-CastroJosé Ramón González-JuanateyHein HeidbuchelAndrea SarkozyMoisés Rodríguez-MañeroPublished in: ESC heart failure (2023)
In the subset of patients referred for AF ablation, the development of AiCM was associated with persistent AF and CKD. Biomarker analysis was not different between groups nor predicted recurrence. Patients with AiCM benefited from ablation, with a significant improvement in left ventricular ejection fraction and similar AF recurrence rates to those without AiCM.
Keyphrases
- ejection fraction
- atrial fibrillation
- catheter ablation
- aortic stenosis
- left atrial
- heart failure
- left atrial appendage
- left ventricular
- oral anticoagulants
- end stage renal disease
- chronic kidney disease
- direct oral anticoagulants
- newly diagnosed
- percutaneous coronary intervention
- radiofrequency ablation
- acute myocardial infarction
- prognostic factors
- high glucose
- drug induced
- venous thromboembolism
- coronary artery disease
- transcatheter aortic valve replacement
- oxidative stress